British Journal of Haematology · 2000 · 75 citations · 26 references
MedicineGeneticsMolecular GeneticsHemostasisMedical GeneticsTranscriptional RegulationCoagulation AbnormalitiesPlatelet ActivationPlatelet AdhesionPlatelet FunctionPlatelet PhysiologyVon Willebrand DiseasePlatelet-platelet InteractionsPlatelet-von Willebrand Factor InteractionsPolymorphism Linkage DisequilibriumSingle-nucleotide Polymorphism AnalysisSingle-nucleotide Polymorphism VariationVon Willebrand Factor FunctionVon Willebrand Factor RegulationVon Willebrand Factor-platelet Interaction
von Willebrand Factor (VWF) is a large multimeric glycoprotein involved in the transport and protection of factor VIII and in mediating platelet-subendothelium and platelet-platelet interactions. We have documented the presence of a single nucleotide polymorphism (SNP) at nucleotide (nt) -1793 (G 0.36 or C 0.64) in the VWF 5'-flanking sequence. This polymorphism is in strong linkage disequilibrium with the previously reported SNPs at nts -1234, -1185 and -1051 and, like this other group of polymorphisms, shows a significant association with plasma VWF levels. This association is more marked in subjects who are more than 40 years of age. Further, circumstantial evidence to support a role for the -1793 sequence in regulating VWF expression comes from our demonstration of differential binding of endothelial cell nuclear proteins, including the transcription factor NFkappaB, by this sequence. In summary, the association of the -1793 SNP with plasma VWF levels provides additional evidence for the role of the VWF regulatory region between nts -1793 and -1051 in controlling VWF expression.
26
The effect of ABO blood group on the diagnosis of von Willebrand disease
JC Gill, J Endres-Brooks, PJ Bauer et al. · Blood · 1987 · 939 citations · Full text
Medicine, Hematology, Pathology +14